Concepedia

New Insight Into Epirubicin Cardiac Toxicity: Competing Risks Analysis of 1097 Breast Cancer Patients

Marianne Ryberg, Dorte Nielsen, Giuliana Cortese, Gitte Nielsen, Torben Skovsgaard, Per Kragh Andersen

JNCI Journal of the National Cancer Institute · 2008 · 173 citations · 23 references

DOIFull text

Open access

Abstract

Maximum cumulative dosages of epirubicin are presented that confer a 5% risk of cardiotoxicity for patients with different sets of risk factors.

References

23

Risk Factors for Doxorubicin-lnduced Congestive Heart Failure

Daniel D. Von Hoff · Annals of Internal Medicine · 1979 · 2.4K citations

, , +13

Congestive heart failure in patients treated with doxorubicin

Sandra M. Swain, Fredrick S. Whaley, Michael S. Ewer · Cancer · 2003 · 2.2K citations · Full text

A Comparison of Letrozole and Tamoxifen in Postmenopausal Women with Early Breast Cancer

New England Journal of Medicine · 2005 · 1.6K citations · Full text

Long-Term Risk of Cardiovascular Disease in 10-Year Survivors of Breast Cancer

Maartje J. Hooning, Akke Botma, Berthe M.P. Aleman et al. · JNCI Journal of the National Cancer Institute · 2007 · 859 citations · Full text

Morbidity and mortality of ischaemic heart disease in high-risk breast-cancer patients after adjuvant postmastectomy systemic treatment with or without radiotherapy: analysis of DBCG 82b and 82c randomised trials

Inger Højris, Marie Overgaard, Jens Christensen et al. · The Lancet · 1999 · 350 citations

, , +10